eloxatin ® 5mg/ml (50mg/10ml)
10ml glass vial -
eloxatin ® 5mg/ml (100mg/20ml)
20ml glass vial -
eloxatin ® 5mg/ml (100mg/20ml) infusion
city medical store - sole proprietorship l.l.c germany - 20ml glass vial - infusion - 5mg/ml (100mg/20ml) - malignant disease,immunosuppresion-cytotoxics
eloxatin ® 5mg/ml (50mg/10ml) infusion
city medical store - sole proprietorship l.l.c germany - 10ml glass vial - infusion - 5mg/ml (50mg/10ml) - malignant disease,immunosuppresion-cytotoxics
eloxatin 50mg vial concentrate for solution for infusion
sanofi-aventis - oxaliplatin - concentrate for solution for infusion - 50 mg
eloxatin 100mg vial concentrate for solution for infusion
sanofi-aventis - oxaliplatin - concentrate for solution for infusion - 100 mg
eloxatin 5mg/ml concentrate for solution for infusion
sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - oxaliplatin - concentrate for solution for infusion - 5mg/ml - other antineoplastic agents: platinumcompounds
eloxatin 100mg/20ml rtu
sanofi-aventis central-east africa - oxaliplatin - solution for infusion - each 20ml ready to use (rtu) solution for infusion contains oxaliplatin 100,0 mg
eloxatin 50mg/10ml rtu
sanofi-aventis central-east africa - oxaliplatin - solution for infusion - each 10ml ready to use (rtu) solution for infusion contains oxaliplatin 50,0 mg
medicinal oxygen linde-hadjikyriakos gas ltd 100% inhalation gas